In the quiet, sun-drenched enclave of Sailfish Point in Stuart, Florida, a remarkable gathering takes place every February. It is a day defined by more than just the coastal scenery; it is a day of purpose, resilience, and a shared, unwavering commitment to humanity. This year marked the 14th annual Keith A. Landesman Fundraiser, a cornerstone event that has evolved from a local tribute into a powerful engine for global scientific advancement. Through the collective generosity of a dedicated community, this year’s event raised more than $330,000, bringing the total contributions of the Keith A. Landesman Memorial Fund to an astounding $2.8 million in support of the Cancer Research Institute (CRI).
The Core Mission: Advancing Immunotherapy
At the heart of this initiative is a singular, driving ambition: to accelerate the development of cancer immunotherapy. By focusing on early-career scientists—the postdoctoral fellows whose bold, unconventional ideas often hold the key to the next medical breakthrough—the Landesman family is effectively shaping the future of oncology.
These funds do not merely support research; they provide the essential runway for young investigators to pursue high-risk, high-reward projects. In the field of immunology, where the goal is to harness the body’s own immune system to identify and destroy cancer cells, fresh perspectives are not just encouraged—they are vital. By investing in the "next generation," the Landesman family ensures that the brightest minds in science have the resources to challenge existing paradigms and uncover novel therapeutic pathways.
A Chronology of Compassion: From Grief to Global Impact
The story of this fundraiser is one of profound transformation. Dr. Keith Landesman, a beloved cardiologist, husband, and father, was a man defined by his desire to heal. When his life was cut short, his family faced an unimaginable void. However, rather than succumbing to the weight of their grief, his parents, Jane and Richard Landesman, chose to channel their sorrow into action.
The Early Days
The roots of this movement trace back to a small, intimate golf tournament held at the Birchwood Country Club in Westport, Connecticut. At the time, it was a modest effort—a way for friends and colleagues to remember a man who had dedicated his own life to the service of others. His brother, Kevin Landesman, recalls, “Keith was the most kind-hearted person I think I’ve ever met. All he wanted to do was help people. That’s why he went into medicine.”
The Evolution of an Annual Tradition
Over the years, as the family relocated and their network expanded, the event grew in both scale and scope. The transition to Sailfish Point in Stuart, Florida, allowed the fundraiser to bloom into a comprehensive experience. Today, the day-long event includes a variety of activities, culminating in an evening program and dinner that brings together supporters, world-class researchers, and those personally touched by the fight against cancer.

What began as a localized memorial has become a beacon of hope, proving that a family’s commitment, when sustained over time, can ripple outward to change the world.
Data and Impact: The Power of Sustained Giving
The $2.8 million raised by the Landesman family is not a static figure; it is a dynamic investment in human capital. Within the scientific community, the CRI postdoctoral fellowship program is considered a gold standard.
- Financial Scope: Over 14 years, the family has successfully mobilized over $2.8 million.
- Scientific Pipeline: Funds are exclusively earmarked for early-career researchers—the individuals most likely to introduce "disruptive" science to the field of immunotherapy.
- Community Engagement: The event’s consistent growth demonstrates a high retention rate of donors, indicating that the community does not just support the cause once, but remains invested year after year.
CRI CEO Dr. Alicia Zhou has frequently highlighted how the Landesmans’ long-term commitment has provided the organization with the stability needed to fund multi-year projects. "The commitment of the Landesman family has shaped a generation of scientific discovery," Dr. Zhou noted during this year’s event. This consistent financial backing allows researchers to move away from the pressure of short-term, "safe" results and toward the long-term, rigorous inquiry required to truly understand complex cancers.
Official Voices: The Human Element of Research
While the financial figures are impressive, the soul of the event lies in the personal testimonies shared at the podium. This year, the audience was privileged to hear from Dr. Haydn Kissick, a CRI STAR and Assistant Professor at the Emory University School of Medicine.
Dr. Kissick’s address was a masterclass in transparency and inspiration. He spoke candidly about his own mother’s years-long battle with cancer, a journey that catalyzed his decision to enter the field of research. By sharing his vision for the next five years of his work, Dr. Kissick provided the audience with a tangible link between their donations and the future of patient care.
"The room is quiet when the speakers are talking," remarked Kara Green, Keith’s sister. "Everyone is mesmerized by what’s being discussed. There’s love, there’s some sadness, every emotion is there—but it’s an incredible event."

This emotional connection is what sets the Keith A. Landesman fundraiser apart. It is not a sterile corporate gala; it is a community of people who, in the words of Kevin Landesman, are "not just writing a check and moving on. They’re there in person, listening to the speakers and really buying into the cause."
Recognition: The Oliver R. Grace Award
The impact of Jane and Richard Landesman’s work did not go unnoticed by the broader medical community. In 2025, the couple was honored with the prestigious Oliver R. Grace Award for Distinguished Service at the CRI Annual Awards Gala. Named after the founding chairman of the Cancer Research Institute, this award is reserved for individuals whose dedication has fundamentally altered the trajectory of the organization.
The acceptance of this award was a poignant moment for the family. While they consistently maintain that they do not seek recognition, the honor serves as a necessary acknowledgement of the sheer scale of their achievement. As Kevin Landesman noted, "It was a wonderful evening for our family to come together and say thank you to our parents for the example they’ve set—showing us what it means to dedicate your life to something bigger than yourself."
Implications: A Model for Future Philanthropy
The success of the Keith A. Landesman Fundraiser offers a compelling blueprint for how family-led philanthropy can drive scientific progress. By maintaining a laser-focus on a specific, high-impact area—immunotherapy—and coupling it with a deeply personal, human-centered narrative, the Landesman family has created a sustainable model of support.
1. The Multiplier Effect
The funds raised by the Landesmans act as "seed money" for brilliant scientists. Once these researchers demonstrate initial success through CRI-funded projects, they often secure larger, federal, or corporate grants. Thus, the $2.8 million provided by the Landesman family has likely enabled tens of millions of dollars in subsequent research funding.
2. The Power of "Annual Consistency"
Many charitable initiatives suffer from "donor fatigue" or lose momentum after a few years. By treating the fundraiser as a year-round project—with planning for the next event beginning almost immediately after the current one concludes—the Landesmans have institutionalized their efforts.

3. Bridging the Gap Between Science and Society
Perhaps the most significant implication of this work is the bridge it builds between the laboratory and the public. Researchers often work in silos, but the Landesman event forces a dialogue between the scientists and the people who rely on their work. This fosters a sense of accountability and shared humanity that is essential for maintaining public trust in medical research.
Conclusion: A Legacy That Endures
As the sun sets on another successful year at Sailfish Point, the legacy of Dr. Keith Landesman continues to grow. It is a legacy that transcends the statistics of money raised or the number of fellowships funded. It is a legacy of love, transformed into a relentless pursuit of knowledge.
The future of cancer treatment is being written in laboratories across the country by young scientists who were given a chance because a family in Florida decided to turn their personal tragedy into a global mission. As Kevin Landesman poignantly reflected, "I think he [Keith] would be unbelievably proud that his legacy lives on through these events."
With each passing year, the Keith A. Landesman Fundraiser reaffirms that while cancer may be a formidable adversary, it is no match for a community that refuses to give up. The work continues, the research advances, and, most importantly, the hope remains—brighter and stronger than ever before.
